D.E. Shaw & Co’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $33.4M | Sell |
193,483
-237,645
| -55% | -$44.1M | 0.02% | 860 |
|
|
2025
Q4 | $86M | Sell |
431,128
-528,409
| -55% | -$95.8M | 0.05% | 456 |
|
|
2025
Q3 | $150M | Buy |
959,537
+352,518
| +58% | +$56M | 0.08% | 273 |
|
|
2025
Q2 | $92.1M | Buy |
+607,019
| New | +$80.9M | 0.07% | 352 |
|
|
2025
Q1 | – | Sell |
-84,656
| Closed | -$14.2M | – | 4333 |
|
|
2024
Q4 | $15.6M | Buy |
+84,656
| New | +$16.3M | 0.01% | 1195 |
|
|
2024
Q1 | – | Sell |
-4,857
| Closed | -$1.15M | – | 4400 |
|
|
2023
Q4 | $1.15M | Buy |
4,857
+3,737
| +334% | +$735K | ﹤0.01% | 3050 |
|
|
2023
Q3 | $219K | Buy |
+1,120
| New | +$230K | ﹤0.01% | 3728 |
|
|
2023
Q2 | – | Sell |
-12,022
| Closed | -$2.43M | – | 4285 |
|
|
2023
Q1 | $2.43M | Sell |
12,022
-22,687
| -65% | -$5.14M | ﹤0.01% | 2540 |
|
|
2022
Q4 | $7.56M | Sell |
34,709
-66,323
| -66% | -$14.5M | 0.01% | 1697 |
|
|
2022
Q3 | $19.9M | Sell |
101,032
-66,438
| -40% | -$14.3M | 0.02% | 851 |
|
|
2022
Q2 | $35.8M | Buy |
167,470
+59,310
| +55% | +$14.5M | 0.04% | 549 |
|
|
2022
Q1 | $30.7M | Buy |
108,160
+107,148
| +10,588% | +$33M | 0.03% | 741 |
|
|
2021
Q4 | $381K | Sell |
1,012
-1,815
| -64% | -$705K | ﹤0.01% | 4553 |
|
|
2021
Q3 | $1.17M | Buy |
2,827
+1,985
| +236% | +$824K | ﹤0.01% | 3483 |
|
|
2021
Q2 | $311K | Buy |
+842
| New | +$281K | ﹤0.01% | 4256 |
|
|
2021
Q1 | – | Sell |
-15,306
| Closed | -$3.82M | – | 4109 |
|
|
2020
Q4 | $3.82M | Sell |
15,306
-7,309
| -32% | -$1.74M | ﹤0.01% | 2080 |
|
|
2020
Q3 | $5.12M | Sell |
22,615
-12,936
| -36% | -$2.68M | 0.01% | 1669 |
|
|
2020
Q2 | $6.2M | Sell |
35,551
-20,693
| -37% | -$3.3M | 0.01% | 1501 |
|
|
2020
Q1 | $7.1M | Buy |
56,244
+13,934
| +33% | +$2.09M | 0.01% | 1205 |
|
|
2019
Q4 | $6.46M | Sell |
42,310
-49,817
| -54% | -$6.9M | 0.01% | 1530 |
|
|
2019
Q3 | $12.2M | Buy |
92,127
+27,430
| +42% | +$3.68M | 0.02% | 1048 |
|
|
2019
Q2 | $9.18M | Sell |
64,697
-52,401
| -45% | -$7.11M | 0.01% | 1185 |
|
|
2019
Q1 | $17M | Buy |
117,098
+16,011
| +16% | +$2.1M | 0.02% | 805 |
|
|
2018
Q4 | $11.4M | Sell |
101,087
-119,307
| -54% | -$14.9M | 0.02% | 1006 |
|
|
2018
Q3 | $29.7M | Buy |
220,394
+63,322
| +40% | +$7.82M | 0.04% | 599 |
|
|
2018
Q2 | $17.6M | Buy |
157,072
+25,154
| +19% | +$2.72M | 0.02% | 780 |
|
|
2018
Q1 | $14.1M | Sell |
131,918
-288,049
| -69% | -$31M | 0.02% | 817 |
|
|
2017
Q4 | $46M | Sell |
419,967
-221,707
| -35% | -$24.1M | 0.06% | 371 |
|
|
2017
Q3 | $69.3M | Buy |
641,674
+107,447
| +20% | +$11M | 0.11% | 233 |
|
|
2017
Q2 | $54M | Sell |
534,227
-26,564
| -5% | -$2.45M | 0.09% | 279 |
|
|
2017
Q1 | $50.4M | Sell |
560,791
-106,507
| -16% | -$9.05M | 0.09% | 284 |
|
|
2016
Q4 | $50.8M | Buy |
667,298
+266,559
| +67% | +$20.2M | 0.09% | 291 |
|
|
2016
Q3 | $33.4M | Buy |
400,739
+112,265
| +39% | +$9.41M | 0.06% | 412 |
|
|
2016
Q2 | $23.8M | Buy |
288,474
+103,746
| +56% | +$8.55M | 0.04% | 485 |
|
|
2016
Q1 | $14M | Sell |
184,728
-52,091
| -22% | -$3.86M | 0.03% | 683 |
|
|
2015
Q4 | $19M | Buy |
236,819
+138,774
| +142% | +$10M | 0.03% | 654 |
|
|
2015
Q3 | $6.23M | Buy |
98,045
+5,014
| +5% | +$360K | 0.01% | 1243 |
|
|
2015
Q2 | $6.54M | Sell |
93,031
-86,655
| -48% | -$6.41M | 0.01% | 1286 |
|
|
2015
Q1 | $14.2M | Buy |
179,686
+74,514
| +71% | +$5.5M | 0.02% | 767 |
|
|
2014
Q4 | $6.69M | Sell |
105,172
-144,227
| -58% | -$9.04M | 0.01% | 1359 |
|
|
2014
Q3 | $14.9M | Sell |
249,399
-82,799
| -25% | -$4.74M | 0.02% | 857 |
|
|
2014
Q2 | $17.8M | Buy |
332,198
+174,945
| +111% | +$9.6M | 0.02% | 757 |
|
|
2014
Q1 | $9.49M | Sell |
157,253
-31,784
| -17% | -$1.85M | 0.01% | 1084 |
|
|
2013
Q4 | $10M | Sell |
189,037
-168,620
| -47% | -$8.47M | 0.01% | 1138 |
|
|
2013
Q3 | $16.5M | Buy |
357,657
+156,580
| +78% | +$7.19M | 0.03% | 684 |
|
|
2013
Q2 | $8.25M | Buy |
+201,077
| New | +$8.62M | 0.02% | 997 |
|
Other funds holding CRL
VCM
VPM
D.E. Shaw & Co's CRL Position: Q1 2026 in Review
D.E. Shaw & Co reduced its Charles River Laboratories (CRL) stake by 55% in Q1 2026, selling an estimated $44.1M and leaving 193,483 shares worth $33.4M. The position accounts for 0.02% of the portfolio, ranked #860.
D.E. Shaw & Co first reported a position in CRL in Q2 2013 and has held it in 46 quarters since. The position peaked at $150M in Q3 2025. 557 funds tracked by Wall St. Rank hold CRL as of Q1 2026.
- D.E. Shaw & Co held 193,483 shares of Charles River Laboratories worth $33.4M as of Q1 2026.
- D.E. Shaw & Co sold 237,645 Charles River Laboratories shares in Q1 2026, an estimated $44.1M.
- Charles River Laboratories made up 0.02% of D.E. Shaw & Co's portfolio in Q1 2026, its #860 holding.
- D.E. Shaw & Co first reported a position in Charles River Laboratories in Q2 2013 and has held it in 46 quarters since.
- D.E. Shaw & Co's Charles River Laboratories position peaked at $150M in Q3 2025.
- 557 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.